Our observations suggest that virotherapy led to epitope spreading in which T cell responses against additional tumor associated antigens was induced, and that VSV-IFNβ-TYRP1 may induce some level of anti-tumor T cell response which are then susceptible to later reinvigoration with ICIs (30). Here, TYRP1 is linked to neoplasm.